SCHEMBL2568601

SCHEMBL2568601

CCCc1c(Cc2ccc(-c3ccccc3C#N)cc2)c(=O)n(C2CCC(CC)(OC(C)=O)CC2)c2ccnn12

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC33A1 O00400 20/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2569856 0.90 SLC33A1 (0.54) SLC33A1
SCHEMBL2570558 0.90 SLC33A1 (0.46) SLC33A1
SCHEMBL2574198 0.89 SLC33A1 (0.46) SLC33A1
SCHEMBL2572385 0.89 SLC33A1 (0.46) SLC33A1
SCHEMBL2568075 0.88 SLC33A1 (0.54) SLC33A1
SCHEMBL1369972 0.88 SLC33A1 (0.60) SLC33A1
SCHEMBL2575168 0.86 SLC33A1 (0.45) SLC33A1
SCHEMBL1373346 0.86 SLC33A1 (0.61) SLC33A1
SCHEMBL1373343 0.86 SLC33A1 (0.61) SLC33A1
SCHEMBL1374218 0.85 SLC33A1 (0.73) SLC33A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2384327-A1 FUSED RING COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
WO-2010087515-A1 FUSED RING COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-05 WO disclosed